960249-81-4Relevant articles and documents
Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition
Ryabtsova, Oksana,Joossens, Jurgen,Van Der Veken, Pieter,Vanden Berghe, Wim,Augustyns, Koen,De Winter, Hans
, p. 5032 - 5038 (2016)
The synthesis and in vitro properties of six analogues of the selective glucocorticoid receptor (GR) agonist GSK866, bearing a warhead for covalent linkage to the glucocorticoid receptor, is described.
NOVEL COMPOUNDS
-
Page/Page column 77-78, (2008/06/13)
The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or auto-immune conditions.